United Kingdom· GB-APID-45524111000001102
Skyclarys 50mg capsules
A omaveloxolone product containing omaveloxolone, registered in United Kingdom by Biogen Idec Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Omaveloxolone is registered in 11 of 19 countries.
Countries holding a registration under ATC N07XX25 (omaveloxolone), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Omaveloxolone · ATC N07XX25
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of omaveloxolone costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Omaveloxolone · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$859.97
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Omaveloxolone
- Manufacturer
- Biogen Idec Ltd
- Country
- United Kingdom (GB)
- ATC code
- N07XX25
- ATC class
- Omaveloxolone
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05713219601924
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Omaveloxolone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSKYCLARYSBiogen Netherlands B.V., Badhoevedorp
- SwitzerlandSkyclarys 50 mg, HartkapselnBiogen Switzerland AG
- FinlandSkyclarysBiogen Netherlands B.V.
- FranceSKYCLARYS 50 mg, géluleBIOGEN NETHERLANDS (PAYS-BAS)
- IrelandSkyclarys 50 mg hard capsulesBiogen Netherlands B.V.
- IcelandSkyclarysBiogen Netherlands B.V.
- NetherlandsSkyclarys 50 mg harde capsulesBiogen Netherlands B.V.
- PolandSkyclarysBiogen Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Skyclarys
- Liechtenstein · Skyclarys
- Norway · Skyclarys
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/37e31db6-585e-4a7b-a71c-08d7d5c9f1ca GET /v1/drugs/37e31db6-585e-4a7b-a71c-08d7d5c9f1ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45524111000001102",
"desc": "Skyclarys 50mg capsules (Biogen Idec Ltd)",
"form": "Oral capsule",
"vpid": "45531611000001106",
"source": "dmd",
"vtm_id": "45525211000001109",
"strength": "50 mg",
"substance": "Omaveloxolone",
"ingredient": "Omaveloxolone",
"supplier_code": "2946001000001103"
}See everything about omaveloxolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.